CTKB [NASD]
Cytek Biosciences, Inc.
Index- P/E- EPS (ttm)-0.01 Insider Own11.80% Shs Outstand134.71M Perf Week6.94%
Market Cap1.54B Forward P/E67.69 EPS next Y0.17 Insider Trans-1.77% Shs Float111.55M Perf Month20.60%
Income-1.00M PEG- EPS next Q0.05 Inst Own53.10% Short Float / Ratio3.56% / 6.65 Perf Quarter-23.46%
Sales154.60M P/S9.97 EPS this Y-100.00% Inst Trans6.31% Short Interest3.97M Perf Half Y-8.52%
Book/sh3.09 P/B3.79 EPS next Y15.33% ROA-0.20% Target Price16.50 Perf Year-13.00%
Cash/sh2.60 P/C4.51 EPS next 5Y- ROE-0.20% 52W Range7.38 - 16.05 Perf YTD14.69%
Dividend- P/FCF- EPS past 5Y- ROI1.50% 52W High-27.04% Beta-
Dividend %- Quick Ratio9.50 Sales past 5Y- Gross Margin61.60% 52W Low58.67% ATR0.58
Employees574 Current Ratio10.70 Sales Q/Q17.70% Oper. Margin-0.30% RSI (14)55.94 Volatility4.35% 5.48%
OptionableYes Debt/Eq0.00 EPS Q/Q295.10% Profit Margin-0.60% Rel Volume0.70 Prev Close11.93
ShortableYes LT Debt/Eq0.00 EarningsNov 09 AMC Payout- Avg Volume596.96K Price11.71
Recom2.20 SMA206.64% SMA500.04% SMA200-3.19% Volume418,422 Change-1.84%
Jan-06-22Resumed Piper Sandler Overweight $20
Dec-30-22 11:54AM
Dec-19-22 08:42AM
Nov-21-22 04:05PM
Nov-15-22 10:00AM
Nov-11-22 05:45AM
05:45PM Loading…
Nov-09-22 05:45PM
04:05PM
Oct-31-22 04:30PM
Oct-26-22 04:05PM
08:00AM
Oct-23-22 07:39PM
Oct-14-22 09:35AM
Sep-07-22 01:27AM
Aug-30-22 04:05PM
Aug-27-22 02:02AM
05:25PM Loading…
Aug-10-22 05:25PM
05:00PM
04:05PM
Jul-23-22 09:17AM
Jul-21-22 08:00AM
Jul-20-22 04:05PM
Jun-01-22 04:05PM
May-24-22 10:00AM
May-11-22 04:05PM
May-07-22 09:23AM
Apr-28-22 04:05PM
08:00AM
Feb-23-22 04:05PM
Feb-16-22 04:05PM
Feb-11-22 08:00AM
05:38PM Loading…
Jan-25-22 05:38PM
Jan-21-22 05:54AM
Jan-05-22 10:00AM
Dec-24-21 12:38AM
Dec-18-21 12:38AM
Nov-25-21 10:00AM
07:35AM
Nov-17-21 10:00AM
Nov-08-21 04:05PM
Nov-03-21 08:00AM
Oct-26-21 04:05PM
Oct-23-21 08:46AM
Oct-07-21 10:00AM
Sep-02-21 04:05PM
04:03PM
Aug-02-21 04:01PM
Jul-27-21 06:00PM
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jeanmonod PatrikChief Financial OfficerJan 24Sale11.053,50038,67576,132Jan 25 07:20 PM
Yan MingChief Technology OfficerJan 19Sale11.0320,000220,6007,946,833Jan 20 06:26 PM
Jiang WenbinPresident and CEOJan 09Sale10.6620,000213,2007,740,314Jan 10 06:26 PM
Jeanmonod PatrikChief Financial OfficerDec 27Sale9.773,50034,19579,632Dec 29 01:03 PM
Yan MingChief Technology OfficerDec 19Sale10.3820,000207,6007,966,833Dec 20 07:07 PM
Jiang WenbinPresident and CEODec 07Sale11.8620,000237,2007,760,314Dec 09 05:57 PM
Ball JackDirectorNov 29Option Exercise0.6923,99916,53326,999Nov 30 07:39 PM
Jeanmonod PatrikChief Financial OfficerNov 25Sale14.303,50050,05083,132Nov 28 06:55 PM
Yan MingChief Technology OfficerNov 21Sale14.6620,000293,2007,986,833Nov 22 06:15 PM
Ball JackDirectorNov 14Option Exercise0.4016,0006,40019,000Nov 16 05:53 PM
Ball JackDirectorNov 14Sale14.6916,000235,0403,000Nov 16 05:53 PM
Jiang WenbinPresident and CEONov 07Sale14.7620,000295,2007,785,820Nov 08 05:44 PM
Jeanmonod PatrikChief Financial OfficerOct 24Sale15.163,50053,06085,563Oct 25 05:38 PM
Yan MingChief Technology OfficerOct 19Sale14.4220,000288,4008,005,624Oct 20 06:18 PM
Jiang WenbinPresident and CEOOct 07Sale14.7920,000295,8007,805,820Oct 11 05:42 PM
Jeanmonod PatrikChief Financial OfficerSep 26Sale12.633,50044,20589,063Sep 28 05:38 PM
Yan MingChief Technology OfficerSep 19Sale12.4220,000248,4008,025,624Sep 20 05:47 PM
Jiang WenbinPresident and CEOSep 07Sale12.8920,000257,8007,825,820Sep 09 08:06 PM
Jeanmonod PatrikChief Financial OfficerAug 24Sale13.453,50047,07592,563Aug 25 06:14 PM
Yan MingChief Technology OfficerAug 19Sale13.6220,000272,4008,045,624Aug 19 07:41 PM
Jiang WenbinPresident and CEOAug 08Sale15.0920,000301,8007,841,541Aug 10 05:59 PM
Jeanmonod PatrikChief Financial OfficerAug 01Sale12.803,50044,80094,994Aug 03 05:49 PM
Yan MingChief Technology OfficerJul 19Sale11.8320,000236,6008,064,415Jul 20 06:14 PM
Jiang WenbinPresident and CEOJul 07Sale11.1920,000223,8007,861,541Jul 08 05:59 PM
Yan MingChief Technology OfficerJun 21Sale10.0620,000201,2008,084,415Jun 22 07:07 PM
Jiang WenbinPresident and CEOJun 07Sale10.7520,000215,0007,881,541Jun 09 08:08 PM
Yan MingChief Technology OfficerMay 19Sale9.9220,000198,4008,104,415May 20 07:19 PM
Jiang WenbinPresident and CEOMay 09Sale8.0120,000160,2007,896,040May 12 09:18 AM
Yan MingChief Technology OfficerApr 19Sale10.3420,000206,8008,122,803Apr 21 08:58 PM
Jiang WenbinPresident and CEOApr 07Sale10.5420,000210,8007,916,040Apr 08 05:33 PM
Yan MingChief Technology OfficerMar 21Sale11.6420,000232,8008,142,803Mar 23 06:03 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 15Buy12.27241,7272,964,99913,381,054Mar 16 05:10 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 14Buy12.35342,1434,223,92613,139,327Mar 16 05:10 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 11Buy12.77337,4924,309,33412,797,184Mar 11 05:27 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 10Buy12.95256,9923,327,58412,459,692Mar 11 05:27 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 09Buy12.9940,154521,75312,202,700Mar 11 05:27 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 08Buy12.86245,7013,160,05912,162,546Mar 08 04:59 PM
Yan MingChief Technology OfficerMar 07Option Exercise0.3573,01125,3258,162,803Mar 08 05:57 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 07Buy12.61337,9014,260,96511,916,845Mar 08 04:59 PM
Jiang WenbinPresident and CEOMar 07Sale12.6520,000253,0527,936,040Mar 08 05:55 PM
Jiang WenbinPresident and CEOMar 04Option Exercise0.2566,66516,6667,956,040Mar 08 05:55 PM
Barnett ValerieGeneral CounselMar 04Option Exercise4.7110,50049,45512,400Mar 08 05:51 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 04Buy12.9963,662827,23011,578,944Mar 08 04:59 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 02Buy12.89138,2551,782,21811,515,282Mar 02 05:29 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 01Buy12.98294,8643,826,30311,377,027Mar 02 05:29 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 28Buy12.978,746113,43011,082,163Mar 02 05:29 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 25Buy12.9918,991246,69911,073,417Feb 25 05:43 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 24Buy13.03186,4672,429,85111,054,426Feb 25 05:43 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 23Buy13.41214,9222,883,11410,867,959Feb 25 05:43 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 22Buy13.46214,9222,892,05510,653,037Feb 22 05:22 PM
Yan MingChief Technology OfficerFeb 22Sale13.4420,000268,8008,089,792Feb 24 05:41 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 18Buy14.12166,2292,346,38910,438,115Feb 22 05:22 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 17Buy14.78166,2292,457,26410,271,886Feb 22 05:22 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 16Buy14.98166,2002,489,37710,105,657Feb 16 07:39 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 15Buy14.99166,2002,490,5249,939,457Feb 16 07:39 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 14Buy14.72166,2292,446,9249,773,257Feb 16 07:39 PM
Yan MingChief Technology OfficerFeb 10Sale15.1120,000302,1068,109,792Feb 14 06:23 PM
Jiang WenbinPresident and CEOFeb 07Sale14.4020,000288,0007,889,375Feb 09 05:52 PM